icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
HIGH REAL-WORLD EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR (EBR/GZR) IN A HCV GENOTYPE 1 (GT1) POPULATION WITH A MIGRATION BACKGROUND AND PREDOMINANT SUBTYPE 1B INFECTION: RESULTS FROM THE GERMAN HEPATITIS C REGISTRY (DHC-R)
 
 
  Reported by Jules Levin
EASL 2019 April 10-14 Vienna
 
Dietrich Huppe 1, Albrecht Stoehr 2, Markus Cornberg 3, Hartwig Klinker 4, Renate Heyne 5, Christine John 6, Karl-Georg Simon 7, Manfred Bilzer 8, Veronika Guenther 9, Janina Bruening 9, Vanessa Witte 9, Claus Niederau 10 1 Gastroenterologische Gemeinschaftspraxis Herne, Herne; 2 ifi - Institute for Interdisciplinary Medicine, Study Centre St. Georg, Hamburg; 3 Hannover Medical School, Hannover; 4 University Hospital Wurzburg, Wurzburg; 5 Leberzentrum am Checkpoint, Berlin; 6 Private Practice of Internal Medicine, Berlin; 7 MVZ Dres. Eisenbach, Simon, Schwarz GbR, Leverkusen; 8 Bilzer Consulting, Munich; 9 MSD Sharp & Dohme GmbH, Haar; 10 Katholisches Klinikum Oberhausen, Oberhausen

0415191

0415192

0415193

0415194

0415195

0415196